Gilead Sciences, Inc. 8-K Report: Major Corporate Update on October 30, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

1. Entity Information:

• Company Name: Gilead Sciences, Inc.
• State of Incorporation: Delaware (DE)
• CIK (Central Index Key): 0000882095
• IRS Employer Identification Number: 94-3047598
• Address: 333 Lakeside Drive, Foster City, CA 94404
• Phone Number: 650-574-3000

2. Filing Information:

• Filing Type: 8-K (a report of unscheduled material events or corporate changes)
• Filing Date: October 30, 2025

3. Stock Information:

• Common Stock Par Value: $0.001 per share
• Ticker Symbol: GILD
• Exchange: NASDAQ

4. Report Context:

• Period Start Date: October 30, 2025
• Period End Date: October 30, 2025

Insights:

• The filing indicates that Gilead Sciences, Inc. has reported a significant event or change that warrants an 8-K filing on the same day as the report.
• The filing is timely, with the reporting date and the period date being the same, suggesting that it pertains to an immediate matter.
• As a public company listed on NASDAQ, Gilead is subject to SEC regulations and must disclose material events that could impact investors.
• The common stock's low par value suggests that the company may have issued a large number of shares to maintain liquidity in the market.

This information is crucial for investors assessing the current status and operations of Gilead Sciences, Inc. and understanding any material developments that could affect the company's financial performance or stock price.